Co-Authors
This is a "connection" page, showing publications co-authored by Ole Søgaard and Mads Kjolby.
Connection Strength
0.761
-
Determination of camostat and its metabolites in human plasma - Preservation of samples and quantification by a validated UHPLC-MS/MS method. Clin Biochem. 2021 Oct; 96:56-62.
Score: 0.239
-
Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial. EClinicalMedicine. 2021 May; 35:100849.
Score: 0.235
-
Camostat mesylate against SARS-CoV-2 and COVID-19-Rationale, dosing and safety. Basic Clin Pharmacol Toxicol. 2021 Feb; 128(2):204-212.
Score: 0.229
-
Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity. EBioMedicine. 2021 Mar; 65:103255.
Score: 0.058